From Casetext: Smarter Legal Research

Hill v. Novartis Pharm. Corp.

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF CALIFORNIA
May 13, 2013
1:06-CV-00939-JSR-SAB (E.D. Cal. May. 13, 2013)

Opinion

1:06-CV-00939-JSR-SAB

05-13-2013

CHRIS HILL, Plaintiff, v. NOVARTIS PHARMACEUTICALS CORPORATION, Defendant.


ORDER

JED S. RAKOFF, U.S.D.J.

Pending before the Court are objections to the designation of four portions of the deposition of Dr. John Thompson -- two designations by the defendant and two by the plaintiff -- that counsel intends to play at trial. See Joint Statement Regarding Objections to Deposition Designations, ECF No. 159. Having reviewed the parties' objections and the portions of the deposition transcript to which they refer, the Court hereby sustains the objections to all four designations.

SO ORDERED.

________________

JED S. RAKOFF, U.S.D.J.
Dated: New York, New York

May 13, 2013


Summaries of

Hill v. Novartis Pharm. Corp.

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF CALIFORNIA
May 13, 2013
1:06-CV-00939-JSR-SAB (E.D. Cal. May. 13, 2013)
Case details for

Hill v. Novartis Pharm. Corp.

Case Details

Full title:CHRIS HILL, Plaintiff, v. NOVARTIS PHARMACEUTICALS CORPORATION, Defendant.

Court:UNITED STATES DISTRICT COURT EASTERN DISTRICT OF CALIFORNIA

Date published: May 13, 2013

Citations

1:06-CV-00939-JSR-SAB (E.D. Cal. May. 13, 2013)